title: Advantages and disadvantages of coils for transcatheter closure of patent ductus arteriosus.
abstract: Different coils have been used to close the patient ductus arteriosus (PDA). In small- and moderate-sized PDA, coils are an adequate alternative to surgery and/or to other devices. The aim of the study is to review and discuss the advantages and disadvantages of using coils (excluding PFM coils PFM Medical, Germany) to close PDA. Cambier was the first to successfully close a PDA using a Gianturco coil. To date, thousands of patients worldwide have undergone transcatheter closure of PDA using this or other types of coils. The use of coils is analyzed with regard to costs in comparison with other therapeutic modalities; techniques--anterograde, retrograde approach, selection of coil size--in relation to the size of the PDA and the available sizes of coils; efficacy of the rate of complete occlusion and the need for reocclusion; and safety in relation to embolization rate, other complications including hemolysis, left pulmonary artery LPA stenosis and coarctation. It is concluded that coils are a cheap alternative for the occlusion of PDA in the small-to-moderate PDA. The technique can be learned quite quickly, it has a high rate of complete occlusion, and has an acceptable rate of safety. The disadvantages include a moderate rate of coil embolization and of hemolysis in patients with residual shunt after coil occlusion in large PDAs. When more than one coil is used, the potential for developing LPA stenosis is high.
authors.affiliation: Cardiovascular Department, MBC J 16, King Faisal Specialist Hospital and RC, P.O. Box 40047, 21499 Jeddah, Saudi Arabia. ogalal@yahoo.com
authors.forename: M Omar
authors.initials: MO
authors.lastname: Galal
mesh_terms: D006328:Cardiac Catheterization; D017023:Coronary Angiography; D004374:Ductus Arteriosus, Patent / Q000628:therapy*; D006461:Hemolysis; D006801:Humans; D019736:Prostheses and Implants / Q000009:adverse effects / Q000191:economics; D011474:Prosthesis Design; D016896:Treatment Outcome